To hear about similar clinical trials, please enter your email below
Trial Title:
Revealing Engagement Patterns Among Endometrial Cancer Patients
NCT ID:
NCT05998798
Condition:
Endometrial Cancer
Conditions: Official terms:
Endometrial Neoplasms
Conditions: Keywords:
endometrial cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
The study intends to investigate the personal experiences of endometrial cancer patients
who take part in a separate clinical study including a specific medication intervention.
The major focus will be on closely following individuals' rates of trial completion and
withdrawal.
The data collected from this study will help improve future outcomes for all endometrial
cancer patients as well as those in under-represented demographic groups.
Criteria for eligibility:
Study pop:
Patients with endometrial cancer who are actively considering enrolling in an
interventional clinical trial for said condition, but have not yet completed enrollment
and randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patients diagnosed with endometrial cancer
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study
including undergoing treatment and scheduled visits and examination.
Exclusion Criteria:
- Refusal of consent
- Women of childbearing potential without a negative pregnancy test; or women who are
lactating.
- Any serious and/or unstable pre-existing medical disorders
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
September 2024
Completion date:
September 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05998798
